JCGGDB Home
キーワード
糖鎖構造
糖鎖構造(GlycoEditor)
糖鎖構造(Sequence Search)
m/z
単糖組成
Glycoscience Explorer (α version)
構造リスト
JCGGDB Glycan Structure
Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST)
JCGGDB ID
JCGG-STR031555
GlyTouCan
G65889KE
version 2
Glycan Information
Glyco Tree
get Image
Composition
Hex 1
Mass Value Search
Gal 1
Structural Isomer Search
Descriptors Computed from Structure
InChIKey
WQZGKKKJIJFFOK-FPRJBGLDSA-N
Copy
InChI
I
n
C
h
I
=
1
S
/
C
6
H
1
2
O
6
/
c
7
-
1
-
2
-
3
(
8
)
4
(
9
)
5
(
1
0
)
6
(
1
1
)
1
2
-
2
/
h
2
-
1
1
H
,
1
H
2
/
t
2
-
,
3
+
,
4
+
,
5
-
,
6
-
/
m
1
/
s
Copy
SMILES
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
Copy
Mass
Monoisotopic Mass
Average Mass
Underivatised
Oligosaccharides
180.0633
180.1576
Permethylated
Oligosaccharides
250.1417
250.292
Peracetylated
Oligosaccharides
390.1162
390.344
Chemical Synthesis
この部分は iframe 対応のブラウザで見てください。
External Links
GlycoEpitope
(Antiglycan Antibody)
GlycoEpitope
GLPD-000062
GLPD-000062
Name:
Galactosylceramide
Alias Name:
Galactocerebroside
Description:
GalCer
Reducing terminal:
(b-1)Cer
GMDB
(MS
n
)
GMDB
OSO-000206
JCGG
JCGG
JGD-000338
JGD-000338
Reducing terminal:
(b-1)Cer
JCGG
JGD-000302
JGD-000302
LipidBank
(Spectral Data)
LipidBank
GSG1136
GSG1136
Name:
galgactocerebroside
Description:
Gal
b
1-1Cer
Reducing terminal:
(b-)Cer
PACDB(Pathogen adhesion)
Pathogen:
Borrelia burgdorferi
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Borrelia hermsii
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Actinobacillus pleuropneumoniae (serotype 1:4074/serotype 2:4226)
Glycan Name:
Galactosyl ceramide (type I/II; ; hydroxylated/non-hydroxylated fatty acids) [
Binding
]
Pathogen:
Escherichia coli (Uropathogenic(UPEC); K12/HB101(pPIL110-54))
Glycan Name:
Galactosyl ceramide (type II; non-hydroxylated fatty acids) [
Binding
]
Pathogen:
Escherichia coli (Uropathogenic(UPEC); K12/HB101(pPIL110-54))
Glycan Name:
Galactosyl ceramide (type I; hydroxylated fatty acids) [
Binding
]
Pathogen:
Actinomyces viscosus (ATCC 19246)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Actinomyces naeslundii (ATCC 12104)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Propionibacterium granulosum
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Neisseria gonorrhoeae
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Escherichia coli
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Escherichia coli
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Human immunodeficiency virus (type 1(HIV-1))
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Mycoplasma pneumoniae (M129; virulent)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Escherichia coli (HB101(pDG1))
Glycan Name:
Galactosyl ceramide (type I/II; ; hydroxylated/non-hydroxylated fatty acids) [
Binding
]
Pathogen:
Escherichia coli (HB101(pDG1))
Glycan Name:
Galactosyl ceramide (type II; non-hydroxylated fatty acids) [
Binding
]
Pathogen:
Rotavirus (Neuraminidase-sensitive; simian:SA11(P2/G3) / bovine:NCDV(P1/G6))
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Rotavirus (Neuraminidase-insensitive; bovine:UK(P5/G6))
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Borrelia burgdorferi (B31/ESP1/TI1)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Propionibacterium granulosum
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Yersinia pestis (pH6 antigen from Escherichia coli(HB101))
Glycan Name:
Galactosyl ceramide (type I; hydroxylated fatty acids) [
Binding
]
Pathogen:
Yersinia pestis (pH6 antigen from Escherichia coli(HB101))
Glycan Name:
Galactosyl ceramide (type II; non-hydroxylated fatty acids) [
Not Binding
]
Pathogen:
Human immunodeficiency virus (type 1(HIV-1); IIIB)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Burkholderia cepacia (BC5/BC7/BC61/NBC1/NBC2/NBC3)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Burkholderia cepacia (BC5/BC7/BC61/NBC1/NBC2/NBC3)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Propionibacterium freudenreichii
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Not Binding
]
Pathogen:
Human immunodeficiency virus (type 1(HIV-1))
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Human immunodeficiency virus (type 1(HIV-1))
Glycan Name:
Galactosyl ceramide (or a derivative) [
Binding
]
Pathogen:
Human immunodeficiency virus (type 1(HIV-1))
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Escherichia coli (Uropathogenic(UPEC); ARD6; serotype O6:K13:H1)
Glycan Name:
Galactosyl ceramide d18:1-h18:0-h24:0 [
Not Binding
]
Pathogen:
Escherichia coli (Uropathogenic(UPEC); ARD6; serotype O6:K13:H1)
Glycan Name:
Galactosyl ceramide t18:0-h22:0-h24:0 [
Binding
]
Pathogen:
Escherichia coli (HB101/13(K12))
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Cytomegalovirus (HCMV; human)
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
Pathogen:
Borrelia burgdorferi
Glycan Name:
Galactosyl ceramide (Galactocerebroside) [
Binding
]
©2008-2009 Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST)
CompositionDescriptors Computed from StructureMassChemical Synthesis
JCGGDB Home
キーワード
糖鎖構造
Glycoscience Explorer (α version)
